## Abstract The original article to which this Erratum refers was published in Cancer (2003) 97(9):2229–35.
Trends in leukemia incidence and survival in the United States (1973–1998)
✍ Scribed by Yang Xie; Stella M. Davies; Ying Xiang; Leslie L. Robison; Julie A. Ross
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 92 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
BACKGROUND
It is estimated that each year, approximately 30,800 individuals will be diagnosed with leukemia in the United States and 21,700 individuals will die of the disease. Although the overall incidence of leukemia has been declining in the United States, recent reports suggest that incidence rates may be increasing for certain age and racial groups.
METHODS
Leukemia incidence (including acute lymphoblastic leukemia [ALL], acute myeloid leukemia [AML], chronic myeloid leukemia [CML], and chronic lymphoblastic leukemia [CLL]) and 5‐year survival rates were obtained from the Surveillance, Epidemiology, and End Results (SEER) program. Specific rates for age (birth–19, 20–44, 45–64, and 65 + years), gender, and race (black, white) were also examined.
RESULTS
A total of 66,404 cases of leukemia were identified for the period 1973–1998 in the nine reporting SEER sites. For children younger than 20 years old, the overall incidence rate of leukemia increased significantly (estimated annual percent change [EAPC] = 0.5%, 95% confidence interval [CI] = 0.1–0.9), whereas the rate decreased significantly among the group 65 years and older (EAPC = − 0.3, 95% CI = − 0.5 to − 0.1). Incidence rates for CLL and CML decreased significantly during this time period, whereas incidence rates for AML remained stable. Children younger than 20 years old experienced a 15% increase in the 5‐year survival rates for both ALL and AML when comparing the two 10‐year periods of 1974–1983 and 1984–1993. In contrast, there was little overall improvement in survival for adults 45 years and older. In particular, there was a notable decrease in the overall 5‐year survival for blacks older than 65 years and for black males older than 44 years.
CONCLUSIONS
Although the current study confirmed some of the results noted in other populations, the observed overall decline in leukemia survival for blacks is surprising and warrants further investigation. Cancer 2003;97:2229–35. © 2003 American Cancer Society.
DOI 10.1002/cncr.11316
📜 SIMILAR VOLUMES
## Abstract Esophageal adenocarcinoma rates may be increasing, whereas, squamous cell carcinoma rates appear to be decreasing in the United States. Previous population‐based research on esophageal cancer has only covered up to 68% of the country. Additional, updated research on a larger percentage
## Abstract ## BACKGROUND. Myelodysplastic syndromes (MDS) became reportable to the Surveillance, Epidemiology, and End Results (SEER) Program (the United States cancer surveillance program) in 2001. This provided the first opportunity to examine the incidence and survival of patients with MDS in
## Abstract ## BACKGROUND In the United States, detection of squamous carcinoma in situ (CIS) by screening has led to reduced rates for invasive squamous carcinoma and lower mortality. Adenocarcinoma in situ (AIS) rates also have increased, but invasive cervical adenocarcinoma rates have not decli